Globally, PD-L1 immunohistochemical determination has strong potential translational applications; further research is needed to dissect the molecular determinants of the expression of such a biomarker, its relationship with tumor microenvironment, and its significance for treatment decisions. Here, CD274 is linked to neoplasm.